These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36350845)

  • 21. Characterization of neonatal and infant enterostomy fluids - part II: Drug solubility.
    de Waal T; Brouwers J; Rayyan M; Stillhart C; Vinarova L; Vinarov Z; Augustijns P
    Int J Pharm; 2023 Jul; 642():123141. PubMed ID: 37321462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach.
    Kossena GA; Charman WN; Boyd BJ; Dunstan DE; Porter CJ
    J Pharm Sci; 2004 Feb; 93(2):332-48. PubMed ID: 14705191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
    Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
    Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K
    AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
    Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
    Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structured solubility behaviour in fed simulated intestinal fluids.
    Silva MI; Khadra I; Pyper K; Halbert GW
    Eur J Pharm Biopharm; 2023 Dec; 193():58-73. PubMed ID: 37890541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.
    Falavigna M; Klitgaard M; Steene E; Flaten GE
    Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational Models of the Intestinal Environment. 3. The Impact of Cholesterol Content and pH on Mixed Micelle Colloids.
    Suys EJA; Warren DB; Porter CJH; Benameur H; Pouton CW; Chalmers DK
    Mol Pharm; 2017 Nov; 14(11):3684-3697. PubMed ID: 28980815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human and simulated intestinal fluids as solvent systems to explore food effects on intestinal solubility and permeability.
    Stappaerts J; Wuyts B; Tack J; Annaert P; Augustijns P
    Eur J Pharm Sci; 2014 Oct; 63():178-86. PubMed ID: 25063035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-existing colloidal phases of human duodenal aspirates: Intraindividual fluctuations and interindividual variability in relation to molecular composition.
    Elvang PA; Bohsen MS; Stein PC; Bauer-Brandl A; Riethorst D; Brouwers J; Augustijns P; Brandl M
    J Pharm Biomed Anal; 2019 Jun; 170():22-29. PubMed ID: 30903926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
    Augustijns P; Wuyts B; Hens B; Annaert P; Butler J; Brouwers J
    Eur J Pharm Sci; 2014 Jun; 57():322-32. PubMed ID: 23994640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
    Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
    Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubility profiling of HIV protease inhibitors in human intestinal fluids.
    Wuyts B; Brouwers J; Mols R; Tack J; Annaert P; Augustijns P
    J Pharm Sci; 2013 Oct; 102(10):3800-7. PubMed ID: 23939880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
    Fagerberg JH; Al-Tikriti Y; Ragnarsson G; Bergström CA
    Mol Pharm; 2012 Jul; 9(7):1942-52. PubMed ID: 22651218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
    Vithani K; Jannin V; Pouton CW; Boyd BJ
    Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF; Joyce SA; Gahan CG; Griffin BT
    Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
    Clarysse S; Brouwers J; Tack J; Annaert P; Augustijns P
    Eur J Pharm Sci; 2011 Jul; 43(4):260-9. PubMed ID: 21570465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding pharmacokinetic food effects using molecular dynamics simulation coupled with physiologically based pharmacokinetic modeling.
    Turner DC; Yin F; Kindt JT; Zhang H
    Biopharm Drug Dispos; 2012 Dec; 33(9):510-21. PubMed ID: 23065939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.